Central Committee on Infectious Disease and Emergency Responses. Hong Kong: Hospital Authority; 2009 Dec 23.

The Task Force on Human Swine Influenza has reviewed the clinical evidence as well as drug insert and came to a consensus on the suggested use of intravenous zanamivir in HA hospitals. When prescribing this drug, clinicians have to follow current policy on the use of unregistered drugs in HA hospitals, to seek approval from the Chief of Service of the department and to inform hospital pharmacy of the administration.

Publication here